Jayesh Desai

Jayesh Desai

UNVERIFIED PROFILE

Are you Jayesh Desai?   Register this Author

Register author
Jayesh Desai

Jayesh Desai

Publications by authors named "Jayesh Desai"

Are you Jayesh Desai?   Register this Author

100Publications

2811Reads

38Profile Views

Lack of clinical activity with crizotinib in a patient with FUS rearranged rhabdomyosarcoma with ALK protein overexpression.

Pathology 2019 Oct 27;51(6):655-657. Epub 2019 Aug 27.

Department of Anatomical Pathology, PathWest, QEII Medical Centre, Nedlands, WA, Australia; School of Pathology and Laboratory Medicine, The University of Western Australia, Crawley, WA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2019.07.004DOI Listing
October 2019

Encorafenib, Binimetinib, and Cetuximab in V600E-Mutated Colorectal Cancer.

N Engl J Med 2019 10 30;381(17):1632-1643. Epub 2019 Sep 30.

From the University of Texas M.D. Anderson Cancer Center, Houston (S.K., V.M.); West Cancer Center and Research Institute, OneOncology, Germantown, TN (A. Grothey); Memorial Sloan Kettering Cancer Center, New York (R.Y., A.K.); University Hospital Gasthuisberg and University of Leuven, Leuven, Belgium (E.V.C., J. Dekervel); the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (J. Desai, C.G.); National Cancer Center Hospital East, Kashiwa, Japan (T.Y.); Hammersmith Hospital, Division of Cancer, Imperial College London (H.W.), and the Sarah Cannon Research Institute and University College London Cancer Institute (H.-T.A.), London, and the Christie NHS Foundation Trust/National Institute for Health Research Manchester Biomedical Research Centre, Manchester (M.B.) - all in the United Kingdom; the University of Campania Luigi Vanvitelli, Naples (F.C.), and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua (F.L., S.L.) - both in Italy; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (Y.S.H., T.-W.K.); the Netherlands Cancer Institute, Amsterdam (N.S., J.H.M.S.); Oslo University Hospital, Oslo (T.K.G.); Hospital Gregorio Marañón, Madrid (P.G.-A., A.C.F.), and Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, UVic, IOB-Quiron, Barcelona (E.E., J.T.) - both in Spain; Odense University Hospital, Odense, Denmark (P.P., L.S.T.); Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia (S.O.); and Array BioPharma, Boulder, CO (A. Gollerkeri, C.K., K.M., M.P., J.C.-B., L.A., V.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1908075DOI Listing
October 2019

The value of networks in driving phase I trials: the Peter MacCallum Cancer Centre experience.

Chin Clin Oncol 2019 Jun;8(3):23

Early Drug Development Program and Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.05.02DOI Listing
June 2019

Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model.

J Gastrointest Surg 2019 03 8;23(3):626-633. Epub 2019 Jan 8.

Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11605-018-4060-y
Publisher Site
http://dx.doi.org/10.1007/s11605-018-4060-yDOI Listing
March 2019

Wither surgical oncology?

ANZ J Surg 2019 01;89(1-2):10-11

Department of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.14758DOI Listing
January 2019

A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours.

Invest New Drugs 2018 12 10;36(6):1026-1036. Epub 2018 Apr 10.

Peter MacCallum Cancer Centre and Royal Melbourne Hospital, University of Melbourne, 305 Grattan St, Melbourne, VIC, 3000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0597-6DOI Listing
December 2018

ASO Author Reflections: Immunotherapy for Solid Tumors: A Review.

Ann Surg Oncol 2018 12 30;25(Suppl 3):974-975. Epub 2018 Oct 30.

Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1245/s10434-018-6966-8
Publisher Site
http://dx.doi.org/10.1245/s10434-018-6966-8DOI Listing
December 2018

An Update on Immunotherapy for Solid Tumors: A Review.

Ann Surg Oncol 2018 Oct 23;25(11):3404-3412. Epub 2018 Jul 23.

Divisions of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-6658-4DOI Listing
October 2018

Nivolumab for the treatment of colorectal cancer.

Expert Rev Anticancer Ther 2018 07 11;18(7):611-618. Epub 2018 Jun 11.

a Division of Cancer Medicine , Peter MacCallum Cancer Centre , Melbourne , Australia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1480942DOI Listing
July 2018

Systematic Review of Clinical Outcomes Following Various Treatment Options for Patients with Extraabdominal Desmoid Tumors.

Ann Surg Oncol 2018 Jun 11;25(6):1544-1554. Epub 2018 Apr 11.

Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-6408-7DOI Listing
June 2018

Precision oncology using a clinician-directed, tailored approach to molecular profiling.

Asia Pac J Clin Oncol 2018 Feb 30;14(1):84-90. Epub 2017 Oct 30.

Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12787DOI Listing
February 2018

On-Line Ion Exchange Liquid Chromatography as a Process Analytical Technology for Monoclonal Antibody Characterization in Continuous Bioprocessing.

Anal Chem 2017 11 18;89(21):11357-11365. Epub 2017 Oct 18.

Biologics & Vaccines, Bioprocess Research and Development, Merck & Co., Inc. , 2000 Galloping Hill Rd, Kenilworth, New Jersey 07033, United States.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/10.1021/acs.analchem.7b02228
Publisher Site
http://dx.doi.org/10.1021/acs.analchem.7b02228DOI Listing
November 2017

Survival Impact of Adjuvant Chemotherapy for Resected Locally Advanced Rectal Adenocarcinoma.

Clin Colorectal Cancer 2017 06 6;16(2):e45-e54. Epub 2016 Oct 6.

Department of Medical Oncology, Eastern Health, Box Hill, Australia; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2016.09.011DOI Listing
June 2017

Variations of Surveillance Practice for Patients with Bone Sarcoma: A Survey of Australian Sarcoma Clinicians.

Sarcoma 2017 28;2017:1837475. Epub 2017 Feb 28.

Victorian Adolescent & Young Adult Cancer Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Children's Cancer Centre, Royal Children's Hospital, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/1837475DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350324PMC
February 2017

Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.

J Clin Oncol 2016 07 25;34(19):2258-64. Epub 2016 Apr 25.

Eva Segelov, St Vincent's Clinical School, University of New South Wales; Subotheni Thavaneswaran, Kristy P. Robledo, Val J. Gebski, Mustafa Khasraw, Kate Wilson, and John Simes, National Health and Medical Research Council Clinical Trials Centre (NHMRC), University of Sydney; Lorraine A. Chantrill, Macarthur Cancer Therapy Centre, Campbelltown Hospital and Kinghorn Cancer Centre; Nick Pavlakis and Mustafa Khasraw, Royal North Shore Hospital University of Sydney, Sydney; Paul M. Waring and Sebastian Lunke, Centre for Translational Pathology, University of Melbourne; Jayesh Desai, Royal Melbourne Hospital; Jayesh Desai and Michael Jefford, Peter MacCallum Cancer Centre; Andrew Haydon, Alfred Hospital; Jeremy D. Shapiro, Cabrini Hospital, Melbourne; Louise M. Nott, Royal Hobart Hospital, Hobart; Christos S. Karapetis, Flinders University and Flinders Medical Centre; Timothy J. Price, Queen Elizabeth Hospital and Lyell McEwin Hospital, Adelaide; Craig Underhill, Border Medical Oncology, Albury-Wodonga; Guy van Hazel, Sir Charles Gairdner Hospital, Perth, Australia; Elena Elez, Vall d'Hebron University Hospital, Barcelona, Spain; Fortunato Ciardiello, Seconda Università degli Studi di Napoli, Naples, Italy; and Harpreet Wasan, Hammersmith Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.6843DOI Listing
July 2016

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.

Sci Transl Med 2016 07;8(346):346ra92

Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia. Department of Medical Oncology, Western Health, St Albans, Victoria 3021, Australia. Department of Medical Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria 3010, Australia. Ludwig Institute for Cancer Research, New York, NY 10017, USA.

View Article

Download full-text PDF

Source
http://stm.sciencemag.org/content/8/346/346ra92.full.pdf
Web Search
http://dx.doi.org/10.1126/scitranslmed.aaf6219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346159PMC
July 2016

Patterns of care for patients with advanced soft tissue sarcoma: experience from Australian sarcoma services.

Clin Sarcoma Res 2016 11;6:11. Epub 2016 Jul 11.

Department of Medical Oncology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, VIC 3002 Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13569-016-0052-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939824PMC
July 2016

Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer.

Oncoimmunology 2016 Jul 29;5(7):e1149667. Epub 2016 Jun 29.

Peter MacCallum Cancer Center and The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne ,Victoria, Australia; The Department of Pathology, University of Melbourne, Melbourne Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1149667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006930PMC
July 2016

Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.

Clin Colorectal Cancer 2016 Jun 13;15(2):e9-e15. Epub 2016 Feb 13.

Systems Biology and Personalised Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Parkville, Melbourne, Australia; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia; Western Health, Department of Medical Oncology, Footscray, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2016.02.007DOI Listing
June 2016

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.

J Clin Oncol 2015 Dec 12;33(34):4032-8. Epub 2015 Oct 12.

Scott Kopetz, Dipen Maru, Van Morris, Filip Janku, and Arvind Dasari, The University of Texas MD Anderson Cancer Center, Houston, TX; Emily Chan, Vanderbilt-Ingram Cancer Center, Nashville, TN; Joel Randolph Hecht, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles; Brian James and Garth Powis, Sanford Burnham Institute, La Jolla; Keith B. Nolop, Plexxikon, Berkeley; Suman Bhattacharya, Genentech, South San Francisco, CA; Peter J. O'Dwyer, Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA; Woonbook Chung and Jean-Pierre J. Issa, Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA; Leonard Saltz, Memorial Sloan-Kettering Cancer Center, New York, NY; and Jayesh Desai and Peter Gibbs, Royal Melbourne Hospital, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/10/12/JCO.2015.63
Web Search
http://jco.ascopubs.org/content/suppl/2015/11/23/33.34.4032.
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.2497
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.63.2497DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669589PMC
December 2015

The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.

Am Soc Clin Oncol Educ Book 2013

From the Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Walter and Eliza Hall Institute for Medical Research, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EdBook_AM.2013.33.e386DOI Listing
November 2015

Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival.

Clin Colorectal Cancer 2015 Sep 7;14(3):185-91. Epub 2015 Mar 7.

Walter & Eliza Hall Institute of Medical Research, Melbourne, Australia; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Australia; University of Melbourne, Melbourne, Australia; Department of Oncology, Western Health, Footscray, Australia; BioGrid Australia, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.02.004DOI Listing
September 2015

Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma.

Clin Cancer Res 2015 Jul 10;21(14):3216-29. Epub 2015 Apr 10.

St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia. Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia. ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506243PMC
July 2015

Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategies.

Target Oncol 2015 Jun 15;10(2):179-88. Epub 2014 Aug 15.

Ludwig Colon Cancer Initiative Laboratory, Ludwig Institute for Cancer Research, Parkville, VIC, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs11523-014-03
Web Search
http://link.springer.com/10.1007/s11523-014-0330-0
Publisher Site
http://dx.doi.org/10.1007/s11523-014-0330-0DOI Listing
June 2015

Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients.

J Cancer Epidemiol 2015 5;2015:189132. Epub 2015 May 5.

Royal Melbourne Hospital, Melbourne, VIC 3050, Australia ; Western Hospital, Footscray, VIC 3011, Australia ; BioGrid Australia, Melbourne, VIC 3050, Australia.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/jce/2015/189132/
Publisher Site
http://dx.doi.org/10.1155/2015/189132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436511PMC
June 2015

Histone deacetylase inhibitors in cancer: what have we learned?

Cancer 2015 Apr 23;121(8):1164-7. Epub 2014 Dec 23.

Department of Medical Oncology, Royal Melbourne Hospital, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29177DOI Listing
April 2015

Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice.

Asia Pac J Clin Oncol 2014 Dec 17;10(4):361-7. Epub 2014 Aug 17.

Western Hospital, Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia; Royal Melbourne Hospital, Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12260DOI Listing
December 2014

Controversies in the management of gastrointestinal stromal tumors.

Asia Pac J Clin Oncol 2014 Sep 27;10(3):216-27. Epub 2014 Mar 27.

Department of Medical Oncology, The Canberra Hospital, Canberra, Australian Capital Territory, Australia; ANU Medical School, Australian National University, Canberra, Australian Capital Territory, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12187DOI Listing
September 2014

KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?

Asia Pac J Clin Oncol 2014 Sep 9;10(3):261-5. Epub 2014 May 9.

Hunter Area Pathology Service, Newcastle, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12201DOI Listing
September 2014

Soft-tissue sarcomas in the Asia-Pacific region: a systematic review.

Asian Pac J Cancer Prev 2013 ;14(11):6821-32

Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China E-mail :

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7314/apjcp.2013.14.11.6821DOI Listing
August 2014

Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling.

Cancer Res 2014 Feb 13;74(3):921-31. Epub 2013 Dec 13.

Authors' Affiliations: Sarcoma Research Group, Discipline of Medicine, Centre for Personalised Cancer Medicine, Faculty of Health Sciences, School of Molecular and Biomedical Science, Departments of Orthopaedics and Trauma and Haematology, Cancer Clinical Trials Unit, Royal Adelaide Hospital; Department of Surgery, Royal Adelaide Hospital and University of Adelaide; ACRF Cancer Genomics Facility, Centre for Cancer Biology, Division of Tissue Pathology, SA Pathology; Centre for Neurological Diseases, Hanson Institute and SA Pathology; Department of Radiology, Queen Elizabeth Hospital; Department of Haematology and Oncology, Basil Hetzel Institute and Queen Elizabeth Hospital; University of Adelaide, Discipline of Surgery, Basil Hetzel Institute, Adelaide; Sarcoma Genomics and Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia; and Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Australia.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/early/2014/01/23/0
Web Search
http://cancerres.aacrjournals.org/content/early/2013/12/13/0
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-2424DOI Listing
February 2014

An Australasian perspective on sarcoma research, translational biology and clinical trials: the Australasian Sarcoma Study Group (ASSG).

Pathology 2014 Feb;46(2):160-3

1Australasian Sarcoma Study Group (ASSG) 2Peter MacCallum Cancer Centre 3Royal Melbourne Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000051DOI Listing
February 2014

Personalized management: inoperable gastrointestinal stromal tumors.

Clin Gastroenterol Hepatol 2014 Jan 24;12(1):130-4. Epub 2013 Aug 24.

Department of Medical Oncology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2013.08.032DOI Listing
January 2014

Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations.

Am J Gastroenterol 2013 Nov 17;108(11):1785-93. Epub 2013 Sep 17.

1] Ludwig Colon Cancer Initiative Laboratory, Ludwig Institute for Cancer Research, Parkville, Victoria, Australia [2] Faculty of Medicine, Dentistry and Health Sciences, Department of Medical Biology, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2013.292DOI Listing
November 2013

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

Crit Rev Oncol Hematol 2013 Feb 2;85(2):121-35. Epub 2012 Jul 2.

Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2012.06.001DOI Listing
February 2013

Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents.

Clin Cancer Res 2013 Feb 18;19(3):657-67. Epub 2012 Dec 18.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, and Graduate School of Biomedical Sciences, University of Texas, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563727PMC
February 2013

Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system.

Crit Rev Oncog 2012 ;17(1):51-67

Royal Melbourne Hospital, Western Hospital, and Ludwig Institute for Cancer Research, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1615/critrevoncog.v17.i1.50DOI Listing
May 2012

Outcomes of patients with maxillofacial osteosarcoma: a review of 15 cases.

J Oral Maxillofac Surg 2012 Mar 20;70(3):734-9. Epub 2011 Jul 20.

Head, Neck Oncology Tumour Stream, Department of Surgery, Royal Melbourne Hospital, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.joms.2011.03.020DOI Listing
March 2012

Dose optimization of tyrosine kinase inhibitors to improve outcomes in GIST.

Asia Pac J Clin Oncol 2012 Mar 20;8(1):43-52. Epub 2012 Feb 20.

Division of Cancer Medicine, Peter MacCallum Cancer Centre and Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2011.01491.xDOI Listing
March 2012

Microsatellite instability status is critical to analysis of survival in stage II colon cancer.

J Clin Oncol 2012 Feb 9;30(6):675-6; author reply 676-7. Epub 2012 Jan 9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.39.7000DOI Listing
February 2012

Optimising the management of soft tissue tumours.

Pathology 2011 Jun;43(4):295-301

ACT Pathology at The Canberra Hospital, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0b013e3283464427DOI Listing
June 2011

Response assessment in gastrointestinal stromal tumor.

Authors:
Jayesh Desai

Int J Cancer 2011 Mar 7;128(6):1251-8. Epub 2011 Jan 7.

Department of Medical Oncology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.25729DOI Listing
March 2011

Analysis of cellular phosphatidylinositol (3,4,5)-trisphosphate levels and distribution using confocal fluorescent microscopy.

Anal Biochem 2010 Nov 25;406(1):41-50. Epub 2010 Jun 25.

Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victsoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ab.2010.06.033DOI Listing
November 2010

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.

Clin Cancer Res 2009 Dec;15(24):7642-7651

Authors' Affiliations: Ludwig Colon Cancer Initiative Laboratory, Ludwig Institute for Cancer Research; Anatomic Pathology Department, Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Clinical Pharmacology, University of Oxford, Oxford, United Kingdom; Department of Medical Genetics, Biomedicum, University of Helsinki, Helsinki, Finland; Group of Molecular Oncology, Nanomedicine Research Program, Molecular Biology and Biochemistry Research Center (Centro de Investigación Bioquímica y Biología Molecular), Vall d'Hebron Hospital Research Institute, Barcelona, Spain; Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, Denmark; and GI Surgical Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1431DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920750PMC
December 2009

Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthood.

Int J Cancer 2009 Jul;125(2):426-31

onTrac@PeterMac, Victorian Adolescent and Young Adult Cancer Service, Peter MacCallum Cancer Center, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24376DOI Listing
July 2009

Thyrotoxicosis during sunitinib treatment for renal cell carcinoma.

Clin Endocrinol (Oxf) 2008 Oct 3;69(4):669-72. Epub 2008 Apr 3.

Endocrine Unit, Austin Health, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2265.2008.03253.xDOI Listing
October 2008

Clinical use of therapies targeting tumor vasculature and stroma.

Curr Cancer Drug Targets 2008 Sep;8(6):498-508

Austin Hospital and Ludwig Institute for Cancer Research, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156800908785699388DOI Listing
September 2008

Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial.

Cancer 2007 May;109(9):1863-9

Department of Medical Oncology, Center for Sarcoma and Bone Oncology and Ludwig Center for Cancer Research, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22609DOI Listing
May 2007

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

Ann Intern Med 2006 Nov;145(9):660-4

Brigham and Women's Hospital, Dana Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00008DOI Listing
November 2006

Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.

J Clin Oncol 2006 May;24(15):2325-31

Department of Surgery,Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.3439DOI Listing
May 2006